• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world, 11 May 2012 (WHO): A(H1N1)pdm09 in the Middle East

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK). Edited.]

Influenza virus activity in the world, 11 May 2012


Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).


Based on FluNet (as of 7 May 2012, 10:00 UTC), during weeks 16 to 17 (15 April 2012 to 28 April 2012), National Influenza Centres (NICs) and other national influenza laboratories from 83 countries, areas or territories reported data.

The WHO GISRS laboratories tested more than 30 585 specimens.

5 297 were positive for influenza viruses, of which 3 343 (63.1%) were typed as influenza A and 1 954 (36.9%) as influenza B.

Of the subtyped influenza A viruses, 308 (13.4%) were influenza A(H1N1)pdm09 and 1 982 (86.6%) were influenza A(H3N2).

Of the characterized B viruses, 85 (37.6%) belonged to the B-Yamagata lineage and 141 (62.4%) to the B-Victoria lineage.



Summary

During weeks 16 and 17 in 2012, laboratory confirmed influenza activity in general was low worldwide. Activity continued to decline in the northern hemisphere.

Influenza A(H3N2) remained the predominant virus subtype detected globally at low levels except in a number of countries where influenza B was dominant virus. Influenza A(H1N1)pdm09 virus was detected to a lesser extent.

In Europe, the number of virus detections declined. Influenza A(H3N2) continued to be the dominant virus in circulation, followed by influenza B.

In North America, influenza A(H3N2) remained the predominant virus subtype in the United States of America, with an increasing proportion of B viruses relative to influenza A viruses observed in recent weeks. Influenza B continued to be the main virus detected in Canada. In Central America influenza activity was low, except in the Dominican Republic where outbreaks of influenza A(H3N2) virus continued to be reported.

In Asia, influenza A(H3N2) and B viruses co-circulated in China, China Hong Kong Special Administrative Region and a number of other countries and areas. Influenza B virus predominated in Japan and the Republic of Korea, while in India both A(H1N1)pdm09 and influenza B viruses co-circulated. Influenza A(H1N1)pdm09 continued to be the main virus detected in Qatar in the Middle East.

In the southern hemisphere, influenza activity remained low with the majority of the virus detections identified as influenza A(H3N2). An increase of influenza B virus activity was observed in the Plurinational State of Bolivia with limited co-circulation of influenza A(H1N1)pdm09 virus.
-
------
 
Back
Top Bottom